Linked Life Data

3150126

Source:http://linkedlifedata.com/resource/pubmed/id/3150126

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1989-6-22
pubmed:abstractText
A double blind cross over trial of Sodium Valproate (Na VPA) vs Magnesium Valproate (Mg VPA) was performed in 122 patients affected by focal or generalized epilepsies. Only modest differences resulted from the comparison between the two drugs: retention was 8% superior in patients treated with Mg VPA, the number of critic episodes and the quantification of interictal events was significantly lower in patients affected by focal epilepsy treated with Mg VPA. The incidence of side effects was the same for the two drugs.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0035-6344
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
223-30
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
[Comparative study of preparations of sodium and magnesium valproate (VPA) in treatment of patients with epileptic seizures].
pubmed:affiliation
Clinica Neurologica, Università Statale G. D'Annunzio, Chieti.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, English Abstract, Controlled Clinical Trial